BiondVax Receives €8m From The European Investment Bank
October 23, 2018 at 02:54 AM EDT
The money from the EIB is in support of manufacturing facility and ongoing Phase 3 clinical trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.